首页 > 最新文献

Frontiers of Medicine最新文献

英文 中文
Mutually reinforcing relationship between Sjögren's syndrome and lung adenocarcinoma: insights from Mendelian randomisation, single-cell, and transcriptomic analyses. Sjögren综合征和肺腺癌之间相互加强的关系:来自孟德尔随机化、单细胞和转录组分析的见解
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-11-10 DOI: 10.1007/s11684-025-1165-z
Kai Xu, Manhua Wang, Zixuan Yang, Yu Tang, Zhen Li, Tao Liu, Yu Wang, Yuqing Wang, Xiaoqian Zhai

Increasing evidence suggests an association between Sjögren's syndrome (SS) and multiple cancers; however, the causal relationships and regulatory mechanisms remain unclear. Using European genome-wide association study data, we employed Mendelian randomisation (MR) and meta-analysis to explore the SS-cancer causality. Bidirectional two-sample MR revealed that SS increased the risk of colorectal (odds ratio (OR) = 1.08) and lung cancers (OR = 1.15), whereas lung (OR = 3.03) and female genital cancers (OR = 6.59) were found to elevate the risk of SS. Co-localisation analysis confirmed bidirectional causality between SS and lung cancer. Summary data-based MR identified HLA-DPB2 as a hub gene, with single-cell RNA and mRNA analyses suggesting its role in memory B cells regulation via MHC-II ligands and lung carcinogenesis. This study demonstrates a mutually positive association between SS and lung cancer, implicating HLA-DPB2 as a potential regulatory gene and offering novel insights into the relationship between SS and cancer, especially lung cancer.

越来越多的证据表明Sjögren综合征(SS)与多种癌症之间存在关联;然而,其因果关系和调控机制尚不清楚。使用欧洲全基因组关联研究数据,我们采用孟德尔随机化(MR)和荟萃分析来探索ss -癌的因果关系。双向双样本磁共振显示,SS增加了结直肠癌(OR = 1.08)和肺癌(OR = 1.15)的风险,而肺癌(OR = 3.03)和女性生殖器癌(OR = 6.59)的风险增加。共定位分析证实了SS与肺癌之间的双向因果关系。基于汇总数据的MR鉴定出HLA-DPB2为枢纽基因,单细胞RNA和mRNA分析表明其通过MHC-II配体调节记忆B细胞和肺癌发生。本研究证实了SS与肺癌之间的相互正相关,提示HLA-DPB2可能是一种潜在的调控基因,并为SS与癌症,特别是肺癌之间的关系提供了新的见解。
{"title":"Mutually reinforcing relationship between Sjögren's syndrome and lung adenocarcinoma: insights from Mendelian randomisation, single-cell, and transcriptomic analyses.","authors":"Kai Xu, Manhua Wang, Zixuan Yang, Yu Tang, Zhen Li, Tao Liu, Yu Wang, Yuqing Wang, Xiaoqian Zhai","doi":"10.1007/s11684-025-1165-z","DOIUrl":"https://doi.org/10.1007/s11684-025-1165-z","url":null,"abstract":"<p><p>Increasing evidence suggests an association between Sjögren's syndrome (SS) and multiple cancers; however, the causal relationships and regulatory mechanisms remain unclear. Using European genome-wide association study data, we employed Mendelian randomisation (MR) and meta-analysis to explore the SS-cancer causality. Bidirectional two-sample MR revealed that SS increased the risk of colorectal (odds ratio (OR) = 1.08) and lung cancers (OR = 1.15), whereas lung (OR = 3.03) and female genital cancers (OR = 6.59) were found to elevate the risk of SS. Co-localisation analysis confirmed bidirectional causality between SS and lung cancer. Summary data-based MR identified HLA-DPB2 as a hub gene, with single-cell RNA and mRNA analyses suggesting its role in memory B cells regulation via MHC-II ligands and lung carcinogenesis. This study demonstrates a mutually positive association between SS and lung cancer, implicating HLA-DPB2 as a potential regulatory gene and offering novel insights into the relationship between SS and cancer, especially lung cancer.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145481297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for mortality in neonatal ARDS: a multicenter retrospective cohort study in China. 中国新生儿ARDS死亡率的危险因素:一项多中心回顾性队列研究
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-11-10 DOI: 10.1007/s11684-025-1163-1
Yang Yang, Chuchu Guo, Yunsu Zou, Jinxin Shen, Yan Guo, Rui Cheng, Ying Xu, Xiao Han

As a life-threatening respiratory syndrome, epidemiological data from China has shown that the mortality rate of neonatal acute respiratory distress syndrome (ARDS) is as high as 12.5%. Nevertheless, studies on the influencing factors of this mortality remain limited. This research enrolled newborns with ARDS who initiated invasive mechanical ventilation (IMV) within 72 hours after birth. A Cox regression model with hazard ratio (HR) was constructed using the least absolute shrinkage and selection operator analysis with the lambda.1se screening criterion. Four characteristic variables were identified: inhaled nitric oxide (iNO), high frequency ventilation (HFV), gestational age (GA), and IMV duration. The Kaplan-Meier curve indicated that infants with a higher GA, receiving iNO, or undergoing HFV had a higher risk of death. Restricted cubic spline analysis further revealed that GA ⩾ 38.785 weeks and IMV duration < 117 hours were associated with a significant mortality risk. A linear trend test confirmed a significant linear relationship between GA and mortality risk. Significant interaction effects were observed between "iNO" and "IMV" as well as between "HFV" and "GA". This study underscores that neonates with advanced GA who require concomitant HFV and iNO therapy are associated with a significantly heightened mortality risk.

新生儿急性呼吸窘迫综合征(ARDS)是一种危及生命的呼吸系统综合征,中国的流行病学资料显示,新生儿急性呼吸窘迫综合征(ARDS)死亡率高达12.5%。然而,对这种死亡率的影响因素的研究仍然有限。本研究纳入了出生后72小时内进行有创机械通气(IMV)的ARDS新生儿。采用最小绝对收缩和选择算子分析,建立了具有风险比(HR)的Cox回归模型。1 . se筛选标准。确定了四个特征变量:吸入一氧化氮(iNO)、高频通气(HFV)、胎龄(GA)和IMV持续时间。Kaplan-Meier曲线显示,GA较高、接受iNO或接受HFV的婴儿死亡风险较高。限制性三次样条分析进一步显示,GA小于38.785周和IMV持续时间< 117小时与显著的死亡风险相关。线性趋势检验证实GA与死亡风险之间存在显著的线性关系。“iNO”与“IMV”之间以及“HFV”与“GA”之间存在显著的互作效应。本研究强调,晚期GA患儿需要同时接受HFV和iNO治疗,其死亡风险显著增加。
{"title":"Risk factors for mortality in neonatal ARDS: a multicenter retrospective cohort study in China.","authors":"Yang Yang, Chuchu Guo, Yunsu Zou, Jinxin Shen, Yan Guo, Rui Cheng, Ying Xu, Xiao Han","doi":"10.1007/s11684-025-1163-1","DOIUrl":"https://doi.org/10.1007/s11684-025-1163-1","url":null,"abstract":"<p><p>As a life-threatening respiratory syndrome, epidemiological data from China has shown that the mortality rate of neonatal acute respiratory distress syndrome (ARDS) is as high as 12.5%. Nevertheless, studies on the influencing factors of this mortality remain limited. This research enrolled newborns with ARDS who initiated invasive mechanical ventilation (IMV) within 72 hours after birth. A Cox regression model with hazard ratio (HR) was constructed using the least absolute shrinkage and selection operator analysis with the lambda.1se screening criterion. Four characteristic variables were identified: inhaled nitric oxide (iNO), high frequency ventilation (HFV), gestational age (GA), and IMV duration. The Kaplan-Meier curve indicated that infants with a higher GA, receiving iNO, or undergoing HFV had a higher risk of death. Restricted cubic spline analysis further revealed that GA ⩾ 38.785 weeks and IMV duration < 117 hours were associated with a significant mortality risk. A linear trend test confirmed a significant linear relationship between GA and mortality risk. Significant interaction effects were observed between \"iNO\" and \"IMV\" as well as between \"HFV\" and \"GA\". This study underscores that neonates with advanced GA who require concomitant HFV and iNO therapy are associated with a significantly heightened mortality risk.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145481308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
China's biosafety/biosecurity governance: evolution, challenges, and architecture design. 中国生物安全/生物安全治理:演变、挑战和架构设计。
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 Epub Date: 2025-09-29 DOI: 10.1007/s11684-025-1158-y
Kaiyuan Min, Yi Zhang, Jiangfeng Liu, Juntao Yang, Feng Cao, Zongchao Peng, Depei Liu
{"title":"China's biosafety/biosecurity governance: evolution, challenges, and architecture design.","authors":"Kaiyuan Min, Yi Zhang, Jiangfeng Liu, Juntao Yang, Feng Cao, Zongchao Peng, Depei Liu","doi":"10.1007/s11684-025-1158-y","DOIUrl":"10.1007/s11684-025-1158-y","url":null,"abstract":"","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"871-878"},"PeriodicalIF":3.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Particulate matter exposure and end-stage renal disease risk in IgA nephropathy. IgA肾病患者的颗粒物暴露与终末期肾病风险
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 Epub Date: 2025-09-29 DOI: 10.1007/s11684-025-1162-2
Yilin Chen, Huan Zhou, Siqing Wang, Lingqiu Dong, Yi Tang, Wei Qin

Long-term exposure to particulate matter has been increasingly implicated in the progression of chronic kidney disease (CKD). However, its impact on IgA nephropathy (IgAN), a leading cause of end-stage renal disease (ESRD), remains unclear. A total of 1768 IgAN patients, confirmed by renal biopsy were included in this cohort study. Long-term exposure to PM2.5 and PM10 was assessed using high-resolution satellite-based data from the China High Air Pollutants (CHAP) dataset. Cox proportional hazards models were used to estimate the associations between PM2.5 or PM10 and ESRD risk, adjusting for demographic, clinical, and biochemical covariates. Over a median follow-up of 3.63 years, 209 participants progressed to ESRD. Higher exposure to both PM2.5 and PM10 was significantly associated with an increased risk, with hazard ratios of 1.62 and 1.36 per 10 µg/m3 increase, respectively. A nonlinear dose-response relationship was observed, with risk increasing markedly beyond threshold levels. Trajectory modeling of prebaseline exposure identified a subgroup with persistently high and fluctuating particulate matter exposure that showed the highest risk. This study provides strong evidence that prolonged exposure to ambient particulate matter contributes to renal disease progression in individuals with IgAN.

长期暴露于颗粒物与慢性肾脏疾病(CKD)进展的关系越来越密切。然而,它对终末期肾病(ESRD)的主要病因IgA肾病(IgAN)的影响尚不清楚。本队列研究共纳入1768例经肾活检证实的IgAN患者。使用来自中国高空气污染物(CHAP)数据集的高分辨率卫星数据评估PM2.5和PM10的长期暴露。Cox比例风险模型用于估计PM2.5或PM10与ESRD风险之间的关系,调整了人口统计学、临床和生化协变量。在中位3.63年的随访中,209名参与者进展为ESRD。暴露在PM2.5和PM10中与风险增加显著相关,风险比分别为每增加10微克/立方米1.62和1.36。观察到非线性剂量-反应关系,风险显著增加超过阈值水平。基线前暴露轨迹建模确定了一个亚组,其暴露水平持续高且波动,显示出最高的风险。本研究提供了强有力的证据,证明长期暴露于环境颗粒物有助于IgAN患者肾脏疾病的进展。
{"title":"Particulate matter exposure and end-stage renal disease risk in IgA nephropathy.","authors":"Yilin Chen, Huan Zhou, Siqing Wang, Lingqiu Dong, Yi Tang, Wei Qin","doi":"10.1007/s11684-025-1162-2","DOIUrl":"10.1007/s11684-025-1162-2","url":null,"abstract":"<p><p>Long-term exposure to particulate matter has been increasingly implicated in the progression of chronic kidney disease (CKD). However, its impact on IgA nephropathy (IgAN), a leading cause of end-stage renal disease (ESRD), remains unclear. A total of 1768 IgAN patients, confirmed by renal biopsy were included in this cohort study. Long-term exposure to PM<sub>2.5</sub> and PM<sub>10</sub> was assessed using high-resolution satellite-based data from the China High Air Pollutants (CHAP) dataset. Cox proportional hazards models were used to estimate the associations between PM<sub>2.5</sub> or PM<sub>10</sub> and ESRD risk, adjusting for demographic, clinical, and biochemical covariates. Over a median follow-up of 3.63 years, 209 participants progressed to ESRD. Higher exposure to both PM<sub>2.5</sub> and PM<sub>10</sub> was significantly associated with an increased risk, with hazard ratios of 1.62 and 1.36 per 10 µg/m<sup>3</sup> increase, respectively. A nonlinear dose-response relationship was observed, with risk increasing markedly beyond threshold levels. Trajectory modeling of prebaseline exposure identified a subgroup with persistently high and fluctuating particulate matter exposure that showed the highest risk. This study provides strong evidence that prolonged exposure to ambient particulate matter contributes to renal disease progression in individuals with IgAN.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"855-864"},"PeriodicalIF":3.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exogenous spexin aggravates renal ischemia reperfusion injury and triggers toxicity in healthy kidneys. 外源性spexin加重肾缺血再灌注损伤并触发健康肾脏的毒性。
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 Epub Date: 2025-09-29 DOI: 10.1007/s11684-025-1159-x
Kadri Kulualp, Meltem Kumaş Kulualp, Zeynep Semen, Gökçen Güvenç Bayram, Aslı Çelik, Melek Yeşim Ak, Osman Yilmaz

Renal ischemia-reperfusion injury (IRI) is a major contributor to acute kidney injury (AKI), leading to substantial morbidity and mortality. Spexin (SPX), a 14-amino acid endogenous peptide involved in metabolic regulation and immune modulation, has not yet been studied in the context of chronic treatment and renal IRI. This study evaluated the effects of exogenous SPX on renal function, histopathological changes, and molecular pathways in both IRI-induced injured and healthy kidneys. Twenty-eight male BALB/c mice were divided into four groups: control, SPX, IRI, and SPX+IRI. IRI was induced by 30 minutes of bilateral renal ischemia followed by 6 hours of reperfusion. Renal injury markers, histopathological changes, inflammatory mediators, apoptotic markers, and fibrosis-related proteins were analyzed. SPX significantly exacerbated IRI-induced kidney injury by activating the Wnt/β-catenin signaling pathway and promoting the upregulation of pro-inflammatory, pro-apoptotic, and pro-fibrotic mediators. It is noteworthy that SPX exerted more severe deleterious nephrotoxic effects in the healthy kidney compared to those observed in the IRI-induced injured kidney. These findings indicate that chronic treatment with SPX administration may have intrinsic pro-inflammatory, pro-apoptotic and fibrotic properties, raising concerns about its therapeutic potential. Further research is needed to clarify its physiological role and therapeutic implications in kidney diseases.

肾缺血再灌注损伤(IRI)是急性肾损伤(AKI)的主要原因,导致大量的发病率和死亡率。SPX是一种由14个氨基酸组成的内源性肽,参与代谢调节和免疫调节,尚未在慢性治疗和肾IRI的背景下进行研究。本研究评估了外源性SPX对iri诱导的损伤和健康肾脏的肾功能、组织病理变化和分子通路的影响。将28只雄性BALB/c小鼠分为对照组、SPX组、IRI组和SPX+IRI组。双侧肾缺血30分钟,再灌注6小时,诱导IRI。分析肾损伤标志物、组织病理学改变、炎症介质、凋亡标志物和纤维化相关蛋白。SPX通过激活Wnt/β-catenin信号通路,促进促炎、促凋亡和促纤维化介质的上调,显著加重了iri诱导的肾损伤。值得注意的是,与在iri诱导的损伤肾脏中观察到的相比,SPX在健康肾脏中产生了更严重的有害肾毒性作用。这些发现表明,SPX慢性治疗可能具有内在的促炎、促凋亡和纤维化特性,引起了人们对其治疗潜力的关注。需要进一步的研究来阐明其在肾脏疾病中的生理作用和治疗意义。
{"title":"Exogenous spexin aggravates renal ischemia reperfusion injury and triggers toxicity in healthy kidneys.","authors":"Kadri Kulualp, Meltem Kumaş Kulualp, Zeynep Semen, Gökçen Güvenç Bayram, Aslı Çelik, Melek Yeşim Ak, Osman Yilmaz","doi":"10.1007/s11684-025-1159-x","DOIUrl":"10.1007/s11684-025-1159-x","url":null,"abstract":"<p><p>Renal ischemia-reperfusion injury (IRI) is a major contributor to acute kidney injury (AKI), leading to substantial morbidity and mortality. Spexin (SPX), a 14-amino acid endogenous peptide involved in metabolic regulation and immune modulation, has not yet been studied in the context of chronic treatment and renal IRI. This study evaluated the effects of exogenous SPX on renal function, histopathological changes, and molecular pathways in both IRI-induced injured and healthy kidneys. Twenty-eight male BALB/c mice were divided into four groups: control, SPX, IRI, and SPX+IRI. IRI was induced by 30 minutes of bilateral renal ischemia followed by 6 hours of reperfusion. Renal injury markers, histopathological changes, inflammatory mediators, apoptotic markers, and fibrosis-related proteins were analyzed. SPX significantly exacerbated IRI-induced kidney injury by activating the Wnt/β-catenin signaling pathway and promoting the upregulation of pro-inflammatory, pro-apoptotic, and pro-fibrotic mediators. It is noteworthy that SPX exerted more severe deleterious nephrotoxic effects in the healthy kidney compared to those observed in the IRI-induced injured kidney. These findings indicate that chronic treatment with SPX administration may have intrinsic pro-inflammatory, pro-apoptotic and fibrotic properties, raising concerns about its therapeutic potential. Further research is needed to clarify its physiological role and therapeutic implications in kidney diseases.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"842-854"},"PeriodicalIF":3.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovation and development of stent retrievers in acute ischemic stroke. 急性缺血性脑卒中支架回收器的创新与发展。
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 Epub Date: 2025-10-30 DOI: 10.1007/s11684-025-1160-4
Nan Zhang, Hongye Xu, Hongjian Zhang, Hongyu Ma, Weilong Hua, Minghao Song, Yongxin Zhang, Jianmin Liu, Lei Zhang, Xiaoxi Zhang, Pengfei Yang

Acute ischemic stroke (AIS) is a cerebrovascular disease characterized by high morbidity, disability, and mortality, posing a significant threat to human health. Endovascular treatment has now been established as a key method for AIS management, in which stent retrievers that can mechanically remove blood clots play a key role in this technique. In recent years, stent retrievers have evolved in complexity and functionality to improve the ability of clot removing and surgical safety. However, the present instruments still have limitations on treatment efficiency, vascular adaptability, and operational precision, posing an urgent need for innovation in the design of stent retrievers. This paper systematically reviewed the structural features and working principles of AIS stent retrievers from the perspective of efficacy evaluation metrics, historical development, recent advancements in stent retrieval technology, and future prospects.

急性缺血性脑卒中(Acute ischemic stroke, AIS)是一种发病率高、致残率高、死亡率高的脑血管疾病,对人类健康构成重大威胁。血管内治疗目前已被确立为AIS治疗的关键方法,其中可以机械去除血栓的支架回收器在该技术中发挥关键作用。近年来,支架回收器在复杂性和功能上不断发展,以提高血栓清除能力和手术安全性。然而,目前的器械在治疗效率、血管适应性、操作精度等方面还存在一定的局限性,迫切需要在支架回收器的设计上进行创新。本文从疗效评价指标、支架回收技术的历史发展、最新进展及未来展望等方面系统综述了AIS支架回收器的结构特点和工作原理。
{"title":"Innovation and development of stent retrievers in acute ischemic stroke.","authors":"Nan Zhang, Hongye Xu, Hongjian Zhang, Hongyu Ma, Weilong Hua, Minghao Song, Yongxin Zhang, Jianmin Liu, Lei Zhang, Xiaoxi Zhang, Pengfei Yang","doi":"10.1007/s11684-025-1160-4","DOIUrl":"https://doi.org/10.1007/s11684-025-1160-4","url":null,"abstract":"<p><p>Acute ischemic stroke (AIS) is a cerebrovascular disease characterized by high morbidity, disability, and mortality, posing a significant threat to human health. Endovascular treatment has now been established as a key method for AIS management, in which stent retrievers that can mechanically remove blood clots play a key role in this technique. In recent years, stent retrievers have evolved in complexity and functionality to improve the ability of clot removing and surgical safety. However, the present instruments still have limitations on treatment efficiency, vascular adaptability, and operational precision, posing an urgent need for innovation in the design of stent retrievers. This paper systematically reviewed the structural features and working principles of AIS stent retrievers from the perspective of efficacy evaluation metrics, historical development, recent advancements in stent retrieval technology, and future prospects.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":"19 5","pages":"789-806"},"PeriodicalIF":3.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145400478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights into potential therapeutic approaches for long COVID. 对长期COVID的潜在治疗方法的见解。
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 Epub Date: 2025-09-25 DOI: 10.1007/s11684-025-1149-z
Jingya Zhao, Yingqi Lyu, Jieming Qu
{"title":"Insights into potential therapeutic approaches for long COVID.","authors":"Jingya Zhao, Yingqi Lyu, Jieming Qu","doi":"10.1007/s11684-025-1149-z","DOIUrl":"10.1007/s11684-025-1149-z","url":null,"abstract":"","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"879-885"},"PeriodicalIF":3.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145137289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision medicine for advanced biliary tract cancer in China: current status and future perspectives. 中国晚期胆道癌的精准医疗:现状与未来展望
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 Epub Date: 2025-10-15 DOI: 10.1007/s11684-025-1144-4
Zhen Huang, Wen Zhang, Yongkun Sun, Dong Yan, Xijie Zhang, Lu Liang, Hong Zhao

Biliary tract cancer (BTC) is a rare group of malignancies that develop from the epithelial lining of the biliary tree and have a poor prognosis. Although chemotherapy is the standard of care for patients with advanced BTC in China, its clinical benefits are moderate. In recent years, the approval of targeted therapies and immunotherapies has provided new avenues for the management of advanced BTC. Nonetheless, the increasing number of personalized medicine approaches has created a challenge for clinicians choosing individualized treatment strategies based on tumor characteristics. In this article, we discuss recent progress in implementing precision medicine approaches for advanced BTC in China and examine genomic profiling studies in Chinese patients with advanced BTC. We also discuss the challenges and opportunities of using precision medicine approaches, as well as the importance of considering population-specific factors and tailoring treatment approaches to improve outcomes for patients with BTC. In addition to providing a comprehensive overview of current and emerging precision medicine approaches for the management of advanced BTC in China, this review article will support clinicians outside of China by serving as a reference regarding the role of patient- and population-specific factors in clinical decision-making for patients with this rare malignancy.

胆道癌(BTC)是一种罕见的恶性肿瘤,起源于胆道上皮,预后较差。虽然化疗是中国晚期BTC患者的标准治疗方案,但其临床疗效一般。近年来,靶向治疗和免疫治疗的批准为晚期BTC的治疗提供了新的途径。尽管如此,越来越多的个性化医疗方法给临床医生选择基于肿瘤特征的个性化治疗策略带来了挑战。在本文中,我们讨论了在中国晚期BTC实施精准医学方法的最新进展,并检查了中国晚期BTC患者的基因组谱研究。我们还讨论了使用精准医学方法的挑战和机遇,以及考虑人群特异性因素和定制治疗方法以改善BTC患者预后的重要性。除了全面概述当前和新兴的精准医学方法在中国晚期BTC的管理之外,这篇综述文章还将作为参考,为中国以外的临床医生提供关于患者和人群特异性因素在这种罕见恶性肿瘤患者临床决策中的作用的参考。
{"title":"Precision medicine for advanced biliary tract cancer in China: current status and future perspectives.","authors":"Zhen Huang, Wen Zhang, Yongkun Sun, Dong Yan, Xijie Zhang, Lu Liang, Hong Zhao","doi":"10.1007/s11684-025-1144-4","DOIUrl":"10.1007/s11684-025-1144-4","url":null,"abstract":"<p><p>Biliary tract cancer (BTC) is a rare group of malignancies that develop from the epithelial lining of the biliary tree and have a poor prognosis. Although chemotherapy is the standard of care for patients with advanced BTC in China, its clinical benefits are moderate. In recent years, the approval of targeted therapies and immunotherapies has provided new avenues for the management of advanced BTC. Nonetheless, the increasing number of personalized medicine approaches has created a challenge for clinicians choosing individualized treatment strategies based on tumor characteristics. In this article, we discuss recent progress in implementing precision medicine approaches for advanced BTC in China and examine genomic profiling studies in Chinese patients with advanced BTC. We also discuss the challenges and opportunities of using precision medicine approaches, as well as the importance of considering population-specific factors and tailoring treatment approaches to improve outcomes for patients with BTC. In addition to providing a comprehensive overview of current and emerging precision medicine approaches for the management of advanced BTC in China, this review article will support clinicians outside of China by serving as a reference regarding the role of patient- and population-specific factors in clinical decision-making for patients with this rare malignancy.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"743-768"},"PeriodicalIF":3.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145291746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lactate and lactylation in tumor immunity. 乳酸和乳酸化在肿瘤免疫中的作用。
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 Epub Date: 2025-09-20 DOI: 10.1007/s11684-025-1148-0
Liu Song, Lingjuan Sun, Song Chen, Peixiang Lan

The Warburg effect, originally discovered by Otto Warburg, refers to the metabolic reprogramming of tumor cells from aerobic oxidation to glycolysis, enabling rapid energy production to support their growth and metastasis. This process is accompanied by the massive production and accumulation of lactate both intracellularly and extracellularly. The resulting acidic microenvironment impairs the normal physiological functions of immune cells and promotes tumor progression. An increasing number of studies indicate that lactate, a key metabolite in the tumor microenvironment (TME), acts as a pivotal immunosuppressive signaling molecule that modulates immune cell function. This review aims to comprehensively examine lactate's role as an immunosuppressive molecule in TME. It focuses on mechanisms such as membrane receptor binding, functional reshaping of immune cells via lactate shuttle transport, epigenetic regulation of gene expression through histone lactylation, and modulation of protein structure and function through nonhistone lactylation, emphasizing lactate's importance in immune regulation within the TME. Ultimately, this review offers novel insights into immunosuppressive therapies aimed at targeting lactate function.

Warburg效应最初由Otto Warburg发现,是指肿瘤细胞从有氧氧化到糖酵解的代谢重编程,使其能够快速产生能量以支持其生长和转移。这个过程伴随着细胞内和细胞外乳酸的大量产生和积累。由此产生的酸性微环境损害了免疫细胞的正常生理功能,促进了肿瘤的发展。越来越多的研究表明,乳酸盐作为肿瘤微环境(tumor microenvironment, TME)的关键代谢物,是调节免疫细胞功能的关键免疫抑制信号分子。本文旨在全面研究乳酸作为免疫抑制分子在TME中的作用。重点研究了膜受体结合、乳酸穿梭运输对免疫细胞的功能重塑、组蛋白乳酸化对基因表达的表观遗传调控、非组蛋白乳酸化对蛋白质结构和功能的调控等机制,强调了乳酸在TME内免疫调节中的重要性。最后,这篇综述为针对乳酸功能的免疫抑制疗法提供了新的见解。
{"title":"Lactate and lactylation in tumor immunity.","authors":"Liu Song, Lingjuan Sun, Song Chen, Peixiang Lan","doi":"10.1007/s11684-025-1148-0","DOIUrl":"10.1007/s11684-025-1148-0","url":null,"abstract":"<p><p>The Warburg effect, originally discovered by Otto Warburg, refers to the metabolic reprogramming of tumor cells from aerobic oxidation to glycolysis, enabling rapid energy production to support their growth and metastasis. This process is accompanied by the massive production and accumulation of lactate both intracellularly and extracellularly. The resulting acidic microenvironment impairs the normal physiological functions of immune cells and promotes tumor progression. An increasing number of studies indicate that lactate, a key metabolite in the tumor microenvironment (TME), acts as a pivotal immunosuppressive signaling molecule that modulates immune cell function. This review aims to comprehensively examine lactate's role as an immunosuppressive molecule in TME. It focuses on mechanisms such as membrane receptor binding, functional reshaping of immune cells via lactate shuttle transport, epigenetic regulation of gene expression through histone lactylation, and modulation of protein structure and function through nonhistone lactylation, emphasizing lactate's importance in immune regulation within the TME. Ultimately, this review offers novel insights into immunosuppressive therapies aimed at targeting lactate function.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"697-720"},"PeriodicalIF":3.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding pain heterogeneity in osteoarthritis patients: a narrative review. 理解骨关节炎患者疼痛的异质性:一个叙述性的回顾。
IF 3.5 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-10-01 Epub Date: 2025-07-26 DOI: 10.1007/s11684-025-1143-5
Lin Li, Xiwei Fan, Ross Crawford, Xinzhan Mao, Louis Jun Ye Ong, Feng Gao, Antonia Rujia Sun, Indira Prasadam

The primary clinical manifestation of osteoarthritis (OA) is pain, yet considerable variability exists in the pain experience among OA patients. This narrative review aims to explore the mechanisms driving OA pain heterogeneity to inform the development of targeted interventions that improve treatment efficacy and patient outcomes. A comprehensive literature search was conducted across multiple databases (PubMed, Scopus, and Google Scholar) for papers published between January 1, 2020, and December 31, 2024. Inclusion criteria focused on studies addressing pain mechanisms and therapeutic interventions in OA. This review identifies key mechanisms of OA pain, including joint alterations, angiogenesis, nervous system involvement, peripheral and central sensitization, and psychosocial factors. It highlights the underlying distinct mechanisms in OA pain, which contribute to the variability in individuals' responses to treatment. It was suggested that interactions between neuroimmune and neurovascular systems are key contributors to chronic pain in OA. This narrative review emphasizes the complexity of OA pain, highlighting the importance of thoroughly understanding the underlying mechanisms for developing personalized and effective pain management strategies. Additional research is required to refine treatment approaches and explore long-term effects.

骨关节炎(OA)的主要临床表现是疼痛,但OA患者的疼痛体验存在相当大的差异。本综述旨在探讨OA疼痛异质性的驱动机制,为有针对性的干预措施的发展提供信息,以提高治疗效果和患者预后。对2020年1月1日至2024年12月31日之间发表的论文在多个数据库(PubMed、Scopus和谷歌Scholar)上进行了全面的文献检索。纳入标准侧重于OA疼痛机制和治疗干预的研究。本文综述了OA疼痛的主要机制,包括关节改变、血管生成、神经系统受累、外周和中枢致敏以及社会心理因素。它强调了OA疼痛的潜在独特机制,这有助于个体对治疗反应的变异性。这表明神经免疫系统和神经血管系统之间的相互作用是OA慢性疼痛的关键因素。这篇叙述性综述强调了骨关节炎疼痛的复杂性,强调了彻底理解潜在机制对于制定个性化和有效的疼痛管理策略的重要性。需要进一步的研究来改进治疗方法并探索长期效果。
{"title":"Understanding pain heterogeneity in osteoarthritis patients: a narrative review.","authors":"Lin Li, Xiwei Fan, Ross Crawford, Xinzhan Mao, Louis Jun Ye Ong, Feng Gao, Antonia Rujia Sun, Indira Prasadam","doi":"10.1007/s11684-025-1143-5","DOIUrl":"10.1007/s11684-025-1143-5","url":null,"abstract":"<p><p>The primary clinical manifestation of osteoarthritis (OA) is pain, yet considerable variability exists in the pain experience among OA patients. This narrative review aims to explore the mechanisms driving OA pain heterogeneity to inform the development of targeted interventions that improve treatment efficacy and patient outcomes. A comprehensive literature search was conducted across multiple databases (PubMed, Scopus, and Google Scholar) for papers published between January 1, 2020, and December 31, 2024. Inclusion criteria focused on studies addressing pain mechanisms and therapeutic interventions in OA. This review identifies key mechanisms of OA pain, including joint alterations, angiogenesis, nervous system involvement, peripheral and central sensitization, and psychosocial factors. It highlights the underlying distinct mechanisms in OA pain, which contribute to the variability in individuals' responses to treatment. It was suggested that interactions between neuroimmune and neurovascular systems are key contributors to chronic pain in OA. This narrative review emphasizes the complexity of OA pain, highlighting the importance of thoroughly understanding the underlying mechanisms for developing personalized and effective pain management strategies. Additional research is required to refine treatment approaches and explore long-term effects.</p>","PeriodicalId":12558,"journal":{"name":"Frontiers of Medicine","volume":" ","pages":"769-788"},"PeriodicalIF":3.5,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144717819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1